DOCSLIB.ORG
Explore
Sign Up
Log In
Upload
Search
Home
» Tags
» Mesulfen
Mesulfen
(12) Patent Application Publication (10) Pub. No.: US 2004/0224012 A1 Suvanprakorn Et Al
Subject Index
N° 17069
Ehealth DSI [Ehdsi V2.2.2-OR] Ehealth DSI – Master Value Set
Marrakesh Agreement Establishing the World Trade Organization
Vr Meds Ex01 3B 0825S Coding Manual Supplement Page 1
Patch Test Concentrations and Vehicles for Testing Contact Allergens
Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued
Wo 2008/127291 A2
Guidelines for Atcvet Classification 2021
(12) Patent Application Publication (10) Pub. No.: US 2003/0068365A1 Suvanprakorn Et Al
X-Ray Microscope Röntgenstrahlmikroskop Microscope À Rayons X
Harmonized Tariff Schedule of the United States (2004) -- Supplement 1 Annotated for Statistical Reporting Purposes
Marrakesh Agreement Establishing the World Trade Organization
Chemical Structure-Related Drug-Like Criteria of Global Approved Drugs
Benzoyl Peroxide Composition for Treating Skin
Applied Tariff Rate
Topical Drugs 35 Francisco M
Top View
ATC-Index Mit DDD-Angaben Für Den Deutschen Arzneimittelmarkt Berlin 2013, 12
ATC-Index Mit DDD-Angaben Für Deutschland Im Jahre 2019
Customs Tariff - Schedule Xxi - 1
Australian Statistics on Medicines 2009
23.9.2003 Official Journal of the European Union
Harmonized Tariff Schedule of the United States (2006) (Rev
ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
Customs Tariff - Schedule Xxi - 1
ICD-10-CM TABLE of DRUGS and CHEMICALS
Fagron Industry Foreword Fagron Worldwide
Compositions and Methods for Treating Blackheads
[Ehdsi V3.0.0-RC1] Ehealth DSI – Master Value Set Catalogue
Harmonized Tariff Schedule of the United States (2003) -- Supplement 1 Annotated for Statistical Reporting Purposes
ICD-10-CM Table of Drugs 2019
Guidelines for Atcvet Classification 2010
Subject Index
MFN Applied Tariff Rates 2010 17Mayo2010
(12) United States Patent (10) Patent No.: US 8,628,794 B2 Sele (45) Date of Patent: Jan
ATC Code Title
Establishment of Framework for Classification/Categorisation and Labelling of Medicinal Drugs and Driving
Australian Statistics on Medicines 2003
Annex 1 Referred to in Chapter 3 Schedules in Relation to Article 5